Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial-Reference-Cited by-同舟云学术

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial

Published:1999-08 Issue:2 Volume:52 Page:137-148
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Saunders Michele,Dische Stanley,Barrett Ann,Harvey Angela,Griffiths Gareth,Parmar Mahesh

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference29 articles.

1. Quality assurance in the CHART clinical trial;Aird;Radiother. Oncol.,1995

2. A phase III study of accelerated radiotherapy with and without carboplatin in non-small cell lung cancer: an interim toxicity analysis of the first 100 patients;Ball;Int. J. Radiat. Oncol. Biol. Phys.,1995

3. A phase III study of conventional and accelerated radiotherapy (RT) with and without carboplatin in unresectable non small cell lung cancer (NSCLC);Ball;Radiother. Oncol.,1996

4. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06;Komaki;Am. J. Clin. Oncol.,1997

5. Interruptions of high dose radiation therapy decrease long term survival of favorable patients with unresectable non small cell carcinoma of the lung: analysis of 1244 cases from three Radiation Therapy Oncology Group (RTOG) Trials;Cox;Int. J. Radiat. Oncol. Biol. Phys.,1993

Cited by 440 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling radiobiology;Physics in Medicine & Biology;2024-09-02

2. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

3. Perspectives thérapeutiques dans la prise en charge des CBNPC de stade III non résécables;Revue des Maladies Respiratoires Actualités;2023-10

4. Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors;Acta Oncologica;2023-09-08

5. Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-03